Annexin Pharmaceuticals AB (OSTO:ANNX) E10: kr-154.98 (As of Mar. 2026)


OSTO:ANNX Annexin Pharmaceuticals AB OSTO:ANNX
23 GF Score
Price kr12.55
! 1 Warning Sign
View Full Analysis

What is Annexin Pharmaceuticals AB E10?

Annexin Pharmaceuticals AB OSTO:ANNX +0.40% 23 E10 is kr-154.98 as of Mar. 2026. GuruFocus rates OSTO:ANNX with a GF Score™ of 23/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Annexin Pharmaceuticals AB's adjusted earnings per share data for the three months ended in Mar. 2026 was kr-1.468. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-154.98 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-27), Annexin Pharmaceuticals AB's current stock price is kr12.55. Annexin Pharmaceuticals AB's E10 for the quarter that ended in Mar. 2026 was kr-154.98. Annexin Pharmaceuticals AB's Shiller PE Ratio of today is .


Annexin Pharmaceuticals AB  (OSTO:ANNX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Annexin Pharmaceuticals AB E10 Related Terms


Annexin Pharmaceuticals AB E10 Historical Data

* Premium members only.

The historical data trend for Annexin Pharmaceuticals AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Annexin Pharmaceuticals AB E10 Chart

Annexin Pharmaceuticals AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -196.75

Annexin Pharmaceuticals AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -201.78 -196.75 -154.98

OSTO:ANNX vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Annexin Pharmaceuticals AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Annexin Pharmaceuticals AB Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Annexin Pharmaceuticals AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Annexin Pharmaceuticals AB's Shiller PE Ratio falls into.


OSTO:ANNX
23GF Score
Annexin Pharmaceuticals AB OSTO:ANNX
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Annexin Pharmaceuticals AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Annexin Pharmaceuticals AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-1.468/133.3862*133.3862
=-1.468

Current CPI (Mar. 2026) = 133.3862.

Annexin Pharmaceuticals AB Quarterly Data

per share eps CPI Adj_EPS
201606 -442.499 101.019 -584.276
201609 -156.705 101.138 -206.672
201612 -22.117 102.022 -28.916
201703 -118.348 102.022 -154.732
201706 -55.232 102.752 -71.699
201709 -20.551 103.279 -26.542
201712 -52.984 103.793 -68.091
201803 -100.510 103.962 -128.957
201806 -30.506 104.875 -38.800
201809 -7.386 105.679 -9.322
201812 -13.205 105.912 -16.631
201903 -15.022 105.886 -18.923
201906 -10.918 106.742 -13.643
201909 -11.881 107.214 -14.781
201912 -18.805 107.766 -23.276
202003 -7.707 106.563 -9.647
202006 -7.753 107.498 -9.620
202009 -5.815 107.635 -7.206
202012 -11.630 108.296 -14.324
202103 -13.083 108.360 -16.105
202106 -5.815 108.928 -7.121
202109 -4.846 110.338 -5.858
202112 -11.149 112.486 -13.221
202203 -3.816 114.825 -4.433
202206 -4.362 118.384 -4.915
202209 -3.271 122.296 -3.568
202212 -3.816 126.365 -4.028
202303 -3.271 127.042 -3.434
202306 -4.809 129.407 -4.957
202309 -6.733 130.224 -6.897
202312 -8.657 131.912 -8.754
202403 -3.940 132.205 -3.975
202406 -3.862 132.716 -3.882
202409 -2.532 132.304 -2.553
202412 -2.689 132.987 -2.697
202503 -1.458 132.825 -1.464
202506 -1.359 133.699 -1.356
202509 -1.507 133.482 -1.506
202512 -1.566 133.386 -1.566
202603 -1.468 133.386 -1.468

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of kr-154.98 mean?
Annexin Pharmaceuticals AB (OSTO:ANNX) has a E10 of kr-154.98 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Annexin Pharmaceuticals AB and its competitors.
Is Annexin Pharmaceuticals AB's E10 too high?
Annexin Pharmaceuticals AB's current E10 is kr-154.98. Overall, Annexin Pharmaceuticals AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Annexin Pharmaceuticals AB's E10 compare to VRTX and REGN?
Annexin Pharmaceuticals AB's E10 of kr-154.98 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Annexin Pharmaceuticals AB and its competitors. Annexin Pharmaceuticals AB's current E10 is kr-154.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Annexin Pharmaceuticals AB stock overvalued right now?
Annexin Pharmaceuticals AB (OSTO:ANNX) has a current E10 of kr-154.98. The current E10 is kr-154.98. Annexin Pharmaceuticals AB's overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Annexin Pharmaceuticals AB (OSTO:ANNX), the current E10 is kr-154.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Annexin Pharmaceuticals AB Business Description

Other Exchanges Q910:Germany
Address Kammakargatan 48, Stockholm, SWE, 111 60
Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.
23GF Score

Get the complete analysis for OSTO:ANNX

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr12.55
Price